Southeast Netherlands Advanced Metastatic Breast Cancer Registry

RecruitingOBSERVATIONAL
Enrollment

7,000

Participants

Timeline

Start Date

January 1, 2007

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Advanced Breast CancerMetastatic Breast Cancer
Trial Locations (1)

Unknown

RECRUITING

Multiple hospitals in the Netherlands (see Eligibility), Maastricht

All Listed Sponsors
collaborator

Novartis

INDUSTRY

collaborator

Pfizer

INDUSTRY

collaborator

Roche Pharma AG

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

collaborator

Eisai Inc.

INDUSTRY

collaborator

Daiichi Sankyo

INDUSTRY

collaborator

AstraZeneca

INDUSTRY

collaborator

Gilead Sciences

INDUSTRY

lead

Academisch Ziekenhuis Maastricht

OTHER